Related Experiment Video
Updated: Jun 16, 2025
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.7K
Assessment of cognitive function in elderly patients with heart failure
Leandro Marques da Silva1, Carla Priscilla Belchior Marques Sampaio2, Nair Eloá Dos Santos Guimarães3
1Universidade Federal do Maranhão, Doctoral Program in Health Sciences - São Luís (MA), Brazil.
Revista Da Associacao Medica Brasileira (1992)
|August 21, 2024
Summary
The Mini-Mental State Examination (MMSE) better identified cognitive deficits in elderly heart failure patients compared to the Montreal Cognitive Assessment (MoCA). This study highlights MMSE
Area of Science:
- Gerontology
- Cardiology
- Neurology
Background:
- Heart failure (HF) is a prevalent condition in the elderly population.
- Cognitive deficits (CD) are common comorbidities in patients with HF.
- Accurate identification of CD is crucial for managing elderly HF patients.
Purpose of the Study:
- To compare the efficacy of the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) in detecting cognitive deficits (CD) among elderly patients diagnosed with heart failure (HF).
Main Methods:
- A cross-sectional, observational study was conducted with 43 elderly HF patients.
- Participants were assessed using a sociodemographic and clinical questionnaire.
- Neurocognitive function was evaluated using both the MMSE and MoCA tests.
Main Results:
- The Mini-Mental State Examination (MMSE) identified cognitive deficits in 25.58% of patients.
- The Montreal Cognitive Assessment (MoCA) identified cognitive deficits in 23.26% of patients.
- The difference in detection rates between MMSE and MoCA was statistically significant (p=0.043).
Conclusions:
- The MMSE demonstrated superior performance over the MoCA in identifying cognitive deficits in this cohort of elderly heart failure patients.
- These findings suggest that the MMSE may be a more effective screening tool for cognitive impairment in this specific population.
Related Concept Videos
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:30Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72
01:23Assessment of the Cardiovascular System I: Subjective Data
293
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
293
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:22Heart Failure Drugs: β-Blockers
324
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352